True Wealth Design’s Bio-Rad Laboratories Class A BIO Stock Holding History

True Wealth Design’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.7K	Sell	16 -6	-27%	-$1.7K	﹤0.01%	1356
2026 Q1	$6.13K	Buy	22 +2	+10%	+$576	﹤0.01%	1130
2025 Q4	$6.06K	Buy	20 +1	+5%	+$312	﹤0.01%	1015
2025 Q3	$5.33K	Buy	+19	New	+$5.17K	﹤0.01%	1058
2025 Q2	–	Sell	-1	Closed	-$244	–	2598
2025 Q1	$244	Sell	1 -13	-93%	-$3.91K	﹤0.01%	1871
2024 Q4	$4.6K	Buy	+14	New	+$4.75K	﹤0.01%	549
2024 Q1	–	Sell	-1	Closed	-$323	–	791
2023 Q4	$323	Hold	1	–	–	﹤0.01%	593
2023 Q3	$359	Hold	1	–	–	﹤0.01%	510
2023 Q2	$380	Hold	1	–	–	﹤0.01%	516
2023 Q1	$480	Buy	+1	New	+$468	﹤0.01%	534

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

True Wealth Design's BIO Position: Q2 2026 in Review

True Wealth Design reduced its Bio-Rad Laboratories Class A (BIO) stake by 27% in Q2 2026, selling an estimated $1.7K and leaving 16 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

True Wealth Design first reported a position in BIO in Q1 2023 and has held it in 10 quarters since. The position peaked at $6.13K in Q1 2026. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

True Wealth Design held 16 shares of Bio-Rad Laboratories Class A worth $4.7K as of Q2 2026.
True Wealth Design sold 6 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.7K.
Bio-Rad Laboratories Class A made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1356 holding.
True Wealth Design first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and has held it in 10 quarters since.
True Wealth Design's Bio-Rad Laboratories Class A position peaked at $6.13K in Q1 2026.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.